USPTO 2015–2025 USPTO PatentsView US Corporation

Globalmed Holdings, LLC

USPTO PatentsView assignee record - 16 granted patents across 9 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B29L (Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles).

RSS updates for this company

The verdict

According to USPTO PatentsView, Globalmed ranks #17,706 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 9 technology areas.

#17,706
of 49,997 US assignees by volume
Top 33%
by Innovation Score (41.4/100)
15.6
avg claims per patent
+450%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17706 · US Corporation #17,706 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 16 grants
  • MID-PACK #17,706/49,997
  • PHOTO-FINISH Gensun Biopharma
  • CPC-NARROW B29L · 9 areas
  • INNOV-PAR 41.4/100
  • CLAIMS-RICH 15.6 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +450% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Gensun Biopharma, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Globalmed’s 41.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Globalmed

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Globalmed's Innovation Score is 41.4/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Globalmed?

Each dot is one of Globalmed’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Globalmed’s own 15.6 claims/patent is ABOVE the 14.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Globalmed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 15.915.91616.1 0102030 Granted patents (volume) Avg claims / patent Gensun Biopharma, Inc. - 16, 14.38Gensun BiopharmaGII Acquisition, LLC - 16, 24.62GII AcquisitionGithub, Inc. - 16, 18.5GithubGivenchy - 16, 1GivenchyGOO Chemical Co., Ltd. - 16, 8.88GOO ChemicalGpower Semiconductor, Inc. - 16, 16.75Gpower Semiconduc…Green Charge Networks LLC - 16, 20.81Green Charge Netw…Guangdong Giwee Technology Co. Ltd. - 16, 8.88Guangdong Giwee T…Globalmed Holdings, LLC - 16, 15.62Globalmed Holdings
Globalmed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Globalmed's grants concentrate

Globalmed Holdings, LLC is a focused PatentsView assignee: 9 CPC subclasses with 62.5% of grants classified under B29L (Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles). Peak complete grant year is 2023 (5 grants) versus a trough of 1 in 2021. By volume, Globalmed sits between Gensun Biopharma, Inc. and Guangdong Giwee Technology Co. Ltd..

Globalmed's three-year grant acceleration

Globalmed Holdings, LLC shows 7 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Globalmed's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Globalmed holds 16 patents at rank #17,690, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Globalmed

By rank, the assignees closest to #17,690 in granted patent volume.

Leaders in B29L (Indexing Scheme Associated With Subclass B29c)

Other assignees with the most granted patents in Globalmed's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Globalmed, neither rank-band nor same-CPC leaders (those blocks stay above). In B29L (Indexing Scheme Associated With Subclass B29c), Globalmed ranks #232 of 2,540 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Globalmed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 33% higher than 67% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 201820202021202220232025 3
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Globalmed Holdings, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 2 12.5%
2020 3 18.8%
2021 1 6.3%
2022 2 12.5%
2023 5 31.3%
2025partial year 3 18.8%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Globalmed Holdings, LLC's patent record in context - here's where to go next.

  • Globalmed Holdings, LLC's lead technology class is B29L (Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles), 62.5% of its portfolio - see every assignee active in that class. Explore B29L
  • Ranked #17,706 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Globalmed Holdings, LLC against Gensun Biopharma, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 41.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.